Featured
Cbd, 'Snake Oil' Or Life-changing? - Volteface in Muswell Hill, London
Cannabis grown to get users high won't provide much in the way of building materials, and hemp grown...
Safety And Tolerability Of Cannabidiol In Parkinson Disease in Salt-Lake-City-Utah
Studies show that CBD can increase AEA concentration by blocking the AEA membrane transporter (AMT) or the...
2021 Research Advisory Panel Of California in Pembroke-Pines-Florida
An open-label pilot study conducted in PD patients showed that oral doses of CBD ranging from 150-400 mg/day, combined with classic antiparkinsonian...
Safety And Side Effects Of Cannabidiol, A Cannabis Sativa ... in Phoenix-Arizona
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and...
The Effects Of Cannabidiol On The Driving Performance Of ... in Tucson-Arizona
An open-label pilot study conducted in PD patients showed that oral doses of CBD ranging from 150-400 mg/day, combined...
Open Label Study Of Cannabidiol In Parkinson's Disease in Columbus-Ohio
An open-label pilot study conducted in PD patients showed that oral doses of CBD ranging from 150-400 mg/day, combined with classic antiparkinsonian agents, reduced psychotic...
Intec Pharma Advances Medical Cannabinoid Development ... in Toledo-Ohio
At low concentrations (sub-micromolar scale), CBD binds to equilibrative nucleoside transporter (ENT), transient receptor potential melastatin type 8 (TRPM8), serotonin 1A receptor (5-HT1A), glycine...
Multi-centre Trial Of Cannabidiol (Cbd) For The Treatment Of ... in Pasadena-Texas
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.PDF] Efficacy and Safety...
Nabilone - Alzforum in Pueblo-Colorado
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular...
Cannabis In Parkinson's Disease — The Patient's Perspective ... in Alexandria-Virginia
An open-label pilot study conducted in PD patients showed that oral doses of CBD ranging from 150-400 mg/day, combined with classic antiparkinsonian agents, reduced psychotic...
Latest Posts
h
Cannabis And The Environment: What Science Tells Us And ... in Muswell Hill, London
News Feature: Cannabis And The Adolescent Brain - Pnas in Muswell Hill, London